Semaglutide es un agonista del receptor GLP-1 aprobado para diabetes tipo 2 y manejo del peso segn formulacin Reduce significativamente la albuminuria y puede desacelerar la progresin de enfermedad renal diabtica El riesgo principal es lesin renal aguda secundaria a deshidratacin por efectos gastrointestinales Requiere monitoreo de funcin renal especialmente en pacientes con ERC preexistente o edad avanzada No requiere ajuste de dosis por funcin renal pero precaucin en eGFR 300 mg/g): Cada 3-6 meses Es crucial realizar monitoreo adicional durante perodos de mayor riesgo, como despus de iniciar semaglutide o despus de aumentos de dosis, particularmente en pacientes con insuficiencia renal preexistente o cuando ocurren efectos gastrointestinales significativos
However, much of the research on BPC-157 has been conducted in animals, and key questions about safety, effectiveness, dosing, and long-term outcomes remain unanswered
By improving insulin sensitivity, Retatrutide may enhance brain energy metabolism
However, thats a combination that warrants serious thought and close monitoring if youre going to pursue it
Questions and Answers: Semaglutide and Rash Semaglutide and Rash Yes, semaglutide can cause a rash as a side effect, although it is relatively uncommon
Frequently Asked Questions Do GLP-1 drugs affect emotions
